$MDBH
MDB Capital Holdings LLC Stock $mdbh

$mdbh Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000149315224044825 Filed on November 12, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development		$723.5K
YoY Change		2489.8%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$8.105M
YoY Change		221.18%
Operating Profit		-$8.720M
YoY Change		1024.53%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income		-$8.440M
YoY Change		170.29%
Income Tax
% Of Pretax Income
Net Earnings		-$7.735M
YoY Change		142.77%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding	4.951M shares	4.296M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents		$16.68M
Short-Term Investments
Other Short-Term Assets		$30.10K
YoY Change		-94.64%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment		$835.8K
YoY Change		-0.78%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets		$2.898M
YoY Change		-83.7%
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets		$2.898M
Total Assets		$34.21M
YoY Change		-21.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue		$51.30K
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities		$6.029M
YoY Change		45.55%
SHAREHOLDERS EQUITY
Retained Earnings		-$31.32M
YoY Change		400.66%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$29.00M
YoY Change
Total Liabilities & Shareholders Equity		$34.21M
YoY Change		-21.29%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$7.735M
YoY Change		142.77%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-4366624
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41751
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite G-150
	dei	Entity Address City Or Town EntityAddressCityOrTown	Addison
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75001
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75001
	dei	City Area Code CityAreaCode	(945)
	dei	Local Phone Number LocalPhoneNumber	262-9010
	dei	Security12b Title Security12bTitle	Class A Common Shares, representing Limited Liability Interests
	dei	Trading Symbol TradingSymbol	MDBH
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	883233	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2495715	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21566877	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	723487	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-3186314	usd
	MDBH	Relienquishment Of Deferred Costs Of Initial Public Offering From Prior Year RelienquishmentOfDeferredCostsOfInitialPublicOfferingFromPriorYear	323224	usd
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q4	srt	Payables To Customers PayablesToCustomers		usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Address Address Line1 EntityAddressAddressLine1	14135 Midway Road
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4950632	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16679428	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6109806	usd
CY2024Q3	us-gaap	Cash And Securities Segregated Under Securities Exchange Commission Regulation CashAndSecuritiesSegregatedUnderSecuritiesExchangeCommissionRegulation	1584734	usd
CY2023Q4	us-gaap	Cash And Securities Segregated Under Securities Exchange Commission Regulation CashAndSecuritiesSegregatedUnderSecuritiesExchangeCommissionRegulation	1247881	usd
CY2024Q3	us-gaap	Grants Receivable GrantsReceivable	553963	usd
CY2023Q4	us-gaap	Grants Receivable GrantsReceivable	882319	usd
CY2024Q3	MDBH	Clearing Deposits Current ClearingDepositsCurrent	516774	usd
CY2023Q4	MDBH	Clearing Deposits Current ClearingDepositsCurrent	260000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	428692	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	523788	usd
CY2024Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	5084197	usd
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	24658611	usd
CY2024Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5566955	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5771634	usd
CY2024Q3	MDBH	Investment Securities At Cost Less Impairment InvestmentSecuritiesAtCostLessImpairment	200000	usd
CY2023Q4	MDBH	Investment Securities At Cost Less Impairment InvestmentSecuritiesAtCostLessImpairment	200000	usd
CY2024Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts	587368	usd
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	69303	usd
CY2024Q3	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	110958	usd
CY2023Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	75328	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	835753	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	866490	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2062015	usd
CY2024Q3	us-gaap	Assets Assets	34210837	usd
CY2023Q4	us-gaap	Assets Assets	42985279	usd
CY2024Q3	us-gaap	Accounts Payable Other Current And Noncurrent AccountsPayableOtherCurrentAndNoncurrent	1044209	usd
CY2023Q4	us-gaap	Accounts Payable Other Current And Noncurrent AccountsPayableOtherCurrentAndNoncurrent	578214	usd
CY2024Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	304271	usd
CY2023Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1105078	usd
CY2024Q3	MDBH	Payables To Noncustomers PayablesToNoncustomers	21	usd
CY2023Q4	MDBH	Payables To Noncustomers PayablesToNoncustomers	1405293	usd
CY2024Q3	srt	Payables To Customers PayablesToCustomers	2361514	usd
CY2024Q3	MDBH	Deferred Grant Reimbursement DeferredGrantReimbursement	137035	usd
CY2023Q4	MDBH	Deferred Grant Reimbursement DeferredGrantReimbursement	140703	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	20000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2181780	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2415889	usd
CY2024Q3	us-gaap	Liabilities Liabilities	6028830	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5665177	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q3	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2023Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-718491	usd
CY2024Q3	us-gaap	Other Operating Income OtherOperatingIncome	104246	usd
CY2024Q3	MDBH	Compensation Costs CompensationCosts	5170772	usd
CY2024Q3	MDBH	Operating Expense Related Party OperatingExpenseRelatedParty	489954	usd
CY2024Q3	us-gaap	Professional Fees ProfessionalFees	850013	usd
CY2024Q3	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	236469	usd
CY2024Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	633799	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7381883	usd
CY2024Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	8105370	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8719615	usd
CY2024Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	279125	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8440490	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-705057	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-7609328	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23109008	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001934642
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
CY2024Q3	us-gaap	Fee Income FeeIncome		usd
CY2023Q3	us-gaap	Fee Income FeeIncome		usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	MDBH	Purchases From Sale Of Investment Securities PurchasesFromSaleOfInvestmentSecurities		usd
	MDBH	Proceeds From Sale Of Investment Securities At Fair Value ProceedsFromSaleOfInvestmentSecuritiesAtFairValue		usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
	MDBH	Proceeds From Warrants Issued As Part Of Investment Banking Deal ProceedsFromWarrantsIssuedAsPartOfInvestmentBankingDeal		usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes		usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
	MDBH	Increase Decrease In Payables To Noncustomers IncreaseDecreaseInPayablesToNoncustomers		usd
	us-gaap	Increase Decrease In Payables To Customers IncreaseDecreaseInPayablesToCustomers		usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
	MDBH	Payments Of Initial Public Offering Costs PaymentsOfInitialPublicOfferingCosts		usd
	MDBH	Payment Of Deferred Costs Of Initial Public Offering PaymentOfDeferredCostsOfInitialPublicOffering		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	MDBH	Modification Of Lease Rightofuse Asset And Lease Liability ModificationOfLeaseRightofuseAssetAndLeaseLiability		usd
	MDBH	Record Rightofuse Asset And Operating Lease Liability RecordRightofuseAssetAndOperatingLeaseLiability		usd
	MDBH	Relienquishment Of Deferred Costs Of Initial Public Offering From Prior Year RelienquishmentOfDeferredCostsOfInitialPublicOfferingFromPriorYear		usd
	MDBH	Investment Securities At Cost Less Impairment Received In Lieu Of Cash Payment InvestmentSecuritiesAtCostLessImpairmentReceivedInLieuOfCashPayment		usd
	MDBH	Issuance Of Warrants To Purchase Class Stock Related To Initial Public Offering IssuanceOfWarrantsToPurchaseClassStockRelatedToInitialPublicOffering		usd
	MDBH	Deferred Costs Of Initial Public Offering DeferredCostsOfInitialPublicOffering		usd
CY2024Q3	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss		usd
CY2023Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss		usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease		usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1		usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases		usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue		usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue		usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1		usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases		usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2023Q1	MDBH	Contract With Customer Liability Amounts Billed Not Recognized ContractWithCustomerLiabilityAmountsBilledNotRecognized		usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized		usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2023Q2	MDBH	Contract With Customer Liability Amounts Billed Not Recognized ContractWithCustomerLiabilityAmountsBilledNotRecognized		usd
CY2023Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized		usd
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2024Q1	MDBH	Contract With Customer Liability Amounts Billed Not Recognized ContractWithCustomerLiabilityAmountsBilledNotRecognized		usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized		usd
CY2024Q2	MDBH	Contract With Customer Liability Amounts Billed Not Recognized ContractWithCustomerLiabilityAmountsBilledNotRecognized		usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2024Q3	MDBH	Contract With Customer Liability Amounts Billed Not Recognized ContractWithCustomerLiabilityAmountsBilledNotRecognized		usd
CY2024Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized		usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
	MDBH	Grants For Equipment Purchased GrantsForEquipmentPurchased		usd
CY2024Q3	us-gaap	Fee Income FeeIncome		usd
CY2024Q3	us-gaap	Interest Expense InterestExpense		usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q4	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2023Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
	dei	Document Type DocumentType	10-Q
	dei	Entity Registrant Name EntityRegistrantName	MDB CAPITAL HOLDINGS, LLC
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2320119	usd
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	60314806	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	49405779	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31318226	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12092927	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	28996580	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	37312852	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	-814573	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	7250	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28182007	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	37320102	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34210837	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42985279	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-786906	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-566215	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	696965	usd
	us-gaap	Fee Income FeeIncome	1303398	usd
	us-gaap	Fee Income FeeIncome	4233120	usd
CY2023Q3	us-gaap	Other Operating Income OtherOperatingIncome	11502	usd
	us-gaap	Other Operating Income OtherOperatingIncome	276633	usd
	us-gaap	Other Operating Income OtherOperatingIncome	140873	usd
CY2024Q3	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	-614245	usd
CY2023Q3	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	-775404	usd
	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	1013816	usd
	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	5070958	usd
CY2023Q3	MDBH	Compensation Costs CompensationCosts	1337771	usd
	MDBH	Compensation Costs CompensationCosts	15188205	usd
	MDBH	Compensation Costs CompensationCosts	3183515	usd
CY2023Q3	MDBH	Operating Expense Related Party OperatingExpenseRelatedParty	273821	usd
	MDBH	Operating Expense Related Party OperatingExpenseRelatedParty	1115200	usd
	MDBH	Operating Expense Related Party OperatingExpenseRelatedParty	829474	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	459585	usd
	us-gaap	Professional Fees ProfessionalFees	2409722	usd
	us-gaap	Professional Fees ProfessionalFees	1241089	usd
CY2023Q3	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	93326	usd
	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	651856	usd
	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	408875	usd
CY2024Q3	MDBH	Clearing And Other Charges ClearingAndOtherCharges	876	usd
CY2023Q3	MDBH	Clearing And Other Charges ClearingAndOtherCharges	3316	usd
	MDBH	Clearing And Other Charges ClearingAndOtherCharges	229338	usd
	MDBH	Clearing And Other Charges ClearingAndOtherCharges	382994	usd
CY2023Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	327896	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1972556	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6929180	usd
CY2024Q3	MDBH	Research And Development Grants ResearchAndDevelopmentGrants	489798	usd
CY2023Q3	MDBH	Research And Development Grants ResearchAndDevelopmentGrants	743320	usd
	MDBH	Research And Development Grants ResearchAndDevelopmentGrants	1807706	usd
	MDBH	Research And Development Grants ResearchAndDevelopmentGrants	2265408	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27936	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1238463	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	67095	usd
CY2023Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2523651	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	22805340	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	6996275	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3299055	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-21791524	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1925317	usd
CY2023Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	176300	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	937985	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	548479	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3122755	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20853539	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1376838	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	63559	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2143	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	384143	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-8440490	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-3186314	usd
	us-gaap	Profit Loss ProfitLoss	-20855682	usd
	us-gaap	Profit Loss ProfitLoss	-1760981	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-177853	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1630383	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-341631	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-7735433	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3008461	usd
	us-gaap	Net Income Loss NetIncomeLoss	-19225299	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1419350	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	37320102	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3812808	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33523582	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3838143	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-4805864	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	32555861	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4066636	usd
CY2024Q3	MDBH	Adjustments To Additional Paid In Capital Ownership Change Of Noncontrolling Interest AdjustmentsToAdditionalPaidInCapitalOwnershipChangeOfNoncontrollingInterest	198	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-8440490	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28182007	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	54126	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1967941	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21195193	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	58951	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	3393274	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24647418	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24647418	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	17444659	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	65411	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	349390	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-3186314	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	39320564	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	39320564	usd
	us-gaap	Profit Loss ProfitLoss	-20855682	usd
	us-gaap	Profit Loss ProfitLoss	-1760981	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-566215	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	696965	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	11717587	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	462467	usd
	MDBH	Accretion Of Investments At Amortized Cost Us Treasury Bills AccretionOfInvestmentsAtAmortizedCostUSTreasuryBills	533790	usd
	MDBH	Accretion Of Investments At Amortized Cost Us Treasury Bills AccretionOfInvestmentsAtAmortizedCostUSTreasuryBills	431776	usd
	MDBH	Purchases From Sale Of Investment Securities PurchasesFromSaleOfInvestmentSecurities	1587500	usd
	MDBH	Proceeds From Sale Of Investment Securities At Fair Value ProceedsFromSaleOfInvestmentSecuritiesAtFairValue	632851	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	225874	usd
	MDBH	Proceeds From Warrants Issued As Part Of Investment Banking Deal ProceedsFromWarrantsIssuedAsPartOfInvestmentBankingDeal	165087	usd
	MDBH	Income Recognized From Warrants Received IncomeRecognizedFromWarrantsReceived	359605	usd
	MDBH	Income Recognized From Warrants Received IncomeRecognizedFromWarrantsReceived	2645620	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	130937	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	137972	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	35630	usd
	MDBH	Accretion Of Deferred Grant Reimbursement AccretionOfDeferredGrantReimbursement	-40904	usd
	MDBH	Accretion Of Deferred Grant Reimbursement AccretionOfDeferredGrantReimbursement	-38880	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-20000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	100000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	258104	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	166957	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-234109	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-96971	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-328356	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-133080	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-95096	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	251718	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	256774	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	464044	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	341348	usd
	MDBH	Increase Decrease In Payables To Noncustomers IncreaseDecreaseInPayablesToNoncustomers	21	usd
	us-gaap	Increase Decrease In Payables To Customers IncreaseDecreaseInPayablesToCustomers	956221	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	158269	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-800807	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-100481	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8620720	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5086987	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	37874534	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	15078020	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	17766330	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	5953312	usd
	MDBH	Proceeds Of Deferred Grant Reimbursement ProceedsOfDeferredGrantReimbursement	37256	usd
	MDBH	Proceeds Of Deferred Grant Reimbursement ProceedsOfDeferredGrantReimbursement	-22455	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	100200	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	355634	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	20045260	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	8746619	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	19999992	usd
	MDBH	Payments Of Initial Public Offering Costs PaymentsOfInitialPublicOfferingCosts	2166698	usd
	MDBH	Payment Of Deferred Costs Of Initial Public Offering PaymentOfDeferredCostsOfInitialPublicOffering	518065	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-518065	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17833294	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	10906475	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	21492926	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7357687	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4952624	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18264162	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26445550	usd
	MDBH	Warrants Received As Part Of Investment Banking Deal WarrantsReceivedAsPartOfInvestmentBankingDeal	359605	usd
	MDBH	Warrants Received As Part Of Investment Banking Deal WarrantsReceivedAsPartOfInvestmentBankingDeal	2480533	usd
	MDBH	Modification Of Lease Rightofuse Asset And Lease Liability ModificationOfLeaseRightofuseAssetAndLeaseLiability	198544	usd
	MDBH	Record Rightofuse Asset And Operating Lease Liability RecordRightofuseAssetAndOperatingLeaseLiability	698249	usd
	MDBH	Investment Securities At Cost Less Impairment Received In Lieu Of Cash Payment InvestmentSecuritiesAtCostLessImpairmentReceivedInLieuOfCashPayment	100000	usd
	MDBH	Issuance Of Warrants To Purchase Class Stock Related To Initial Public Offering IssuanceOfWarrantsToPurchaseClassStockRelatedToInitialPublicOffering	65411	usd
	MDBH	Deferred Costs Of Initial Public Offering DeferredCostsOfInitialPublicOffering	284602	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16679428	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6109806	usd
CY2024Q3	us-gaap	Cash And Securities Segregated Under Federal And Other Regulations CashAndSecuritiesSegregatedUnderFederalAndOtherRegulations	1584734	usd
CY2023Q4	us-gaap	Cash And Securities Segregated Under Federal And Other Regulations CashAndSecuritiesSegregatedUnderFederalAndOtherRegulations	1247881	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18264162	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7357687	usd
CY2024Q2	us-gaap	Advances To Affiliate AdvancesToAffiliate	150000	usd
CY2024Q2	us-gaap	Investments Investments	5000000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zckH4v1TbSig" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zd5zjpM9ze5e">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period, as well as the disclosure of contingent assets and liabilities. Some of those judgments can be subjective and complex, and therefore, actual results could differ materially from those estimates under different assumptions or conditions. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates. Significant estimates include those related to assumptions used in the valuation of investment securities, valuing equity instruments issued for services, stock-based compensation and the realization of any deferred tax assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q3	MDBH	Cash Sipc Insured Amount CashSIPCInsuredAmount	500000	usd
CY2024Q3	us-gaap	Cash And Securities Segregated Under Federal And Other Regulations CashAndSecuritiesSegregatedUnderFederalAndOtherRegulations	1584734	usd
CY2023Q4	us-gaap	Cash And Securities Segregated Under Securities Exchange Commission Regulation CashAndSecuritiesSegregatedUnderSecuritiesExchangeCommissionRegulation	1247881	usd
CY2024Q3	MDBH	Clearing Deposits Current ClearingDepositsCurrent	516774	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	428692	usd
	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	43500	usd
	MDBH	Prepaid Professional Fees PrepaidProfessionalFees	75000	usd
CY2024Q3	us-gaap	Security Deposit SecurityDeposit	47380	usd
	MDBH	Prepaid Lab Equipment PrepaidLabEquipment	85000	usd
CY2024Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	147712	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	30100	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	523788	usd
CY2023	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	43500	usd
CY2023	MDBH	Prepaid Professional Fees PrepaidProfessionalFees	95000	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	47380	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	325777	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	12131	usd
CY2024Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	5084197	usd
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	24658611	usd
CY2024Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5566955	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5771634	usd
CY2024Q3	MDBH	Investment Securities At Cost Less Impairment Non Broker Dealer InvestmentSecuritiesAtCostLessImpairmentNonBrokerDealer	200000	usd
CY2023Q4	MDBH	Investment Securities At Cost Less Impairment Non Broker Dealer InvestmentSecuritiesAtCostLessImpairmentNonBrokerDealer	200000	usd
CY2024Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-718491	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-786906	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-566215	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	696965	usd
CY2024Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	5084197	usd
CY2024Q3	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	1160	usd
CY2024Q3	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	5085357	usd
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	24658611	usd
CY2023Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	6031	usd
CY2023Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	24664642	usd
CY2024Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5566955	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3133458	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3133458	usd
	MDBH	Fair Value Measurement With Unobservable Input Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	-387403	usd
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	2746055	usd
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	2746055	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5771634	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease	2645620	usd
CY2023	MDBH	Fair Value Measurement With Unobservable Input Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	652925	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	165087	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3133458	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3133458	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1496887	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1327809	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	661134	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	461319	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	835753	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	866490	usd
	MDBH	Contract With Customer Liability Amounts Billed Not Recognized ContractWithCustomerLiabilityAmountsBilledNotRecognized	100000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	80000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	20000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	20000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	20000	usd
CY2023Q4	us-gaap	Grants Receivable GrantsReceivable	882319	usd
CY2022Q4	us-gaap	Grants Receivable GrantsReceivable	809532	usd
	MDBH	Grant Costs Expensed GrantCostsExpensed	1756852	usd
	MDBH	Grant Costs Expensed GrantCostsExpensed	2180581	usd
	MDBH	Grants For Equipment Purchased GrantsForEquipmentPurchased	6379	usd
	MDBH	Grant Fees GrantFees	50854	usd
	MDBH	Grant Fees GrantFees	84827	usd
	MDBH	Grant Funds Received GrantFundsReceived	-2142441	usd
	MDBH	Grant Funds Received GrantFundsReceived	-2398488	usd
CY2024Q3	us-gaap	Grants Receivable GrantsReceivable	553963	usd
CY2023Q3	us-gaap	Grants Receivable GrantsReceivable	676452	usd
	MDBH	Grant Costs Expensed GrantCostsExpensed	1756852	usd
	MDBH	Grant Costs Expensed GrantCostsExpensed	2180581	usd
	MDBH	Grant Drawdowns GrantDrawdowns	1814085	usd
	MDBH	Grant Drawdowns GrantDrawdowns	2265408	usd
CY2024Q3	MDBH	Research And Development Expense Gross ResearchAndDevelopmentExpenseGross	1213285	usd
CY2023Q3	MDBH	Research And Development Expense Gross ResearchAndDevelopmentExpenseGross	771256	usd
	MDBH	Research And Development Expense Gross ResearchAndDevelopmentExpenseGross	3046169	usd
	MDBH	Research And Development Expense Gross ResearchAndDevelopmentExpenseGross	2332503	usd
CY2024Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	148456	usd
CY2023Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	43196	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	210993	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	107925	usd
CY2024Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	2897768	usd
CY2024Q3	us-gaap	Assets Assets	34210837	usd
CY2024Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-718491	usd
CY2024Q3	us-gaap	Other Operating Income OtherOperatingIncome	104246	usd
CY2024Q3	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	-614245	usd
CY2024Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5170772	usd
CY2024Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	489954	usd
CY2024Q3	us-gaap	Professional Fees ProfessionalFees	850013	usd
CY2024Q3	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	236469	usd
CY2024Q3	MDBH	Clearing And Other Charges ClearingAndOtherCharges	876	usd
CY2024Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	633799	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7381883	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	723487	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	8105370	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8719615	usd
CY2024Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	279125	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8440490	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-8440490	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-705057	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-7735433	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-566215	usd
	us-gaap	Fee Income FeeIncome	1303398	usd
	us-gaap	Other Operating Income OtherOperatingIncome	276633	usd
	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	1013816	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	15188205	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1115200	usd
	us-gaap	Professional Fees ProfessionalFees	2409722	usd
	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	651856	usd
	MDBH	Clearing And Other Charges ClearingAndOtherCharges	229338	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1972556	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21566877	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1238463	usd
	us-gaap	Operating Expenses OperatingExpenses	22805340	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-21791524	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	937985	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20853539	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2143	usd
	us-gaap	Profit Loss ProfitLoss	-20855682	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1630383	usd
	us-gaap	Net Income Loss NetIncomeLoss	-19225299	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3186609	usd
CY2023Q4	us-gaap	Assets Assets	42985279	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-786906	usd
CY2023Q3	us-gaap	Other Operating Income OtherOperatingIncome	11502	usd
CY2023Q3	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	-775404	usd
CY2023Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1337771	usd
CY2023Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	273821	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	459585	usd
CY2023Q3	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	93326	usd
CY2023Q3	MDBH	Clearing And Other Charges ClearingAndOtherCharges	3316	usd
CY2023Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	327896	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2495715	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27936	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	2523651	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3299055	usd
CY2023Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	176300	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3122755	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	63559	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-3186314	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-177853	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3008461	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	696965	usd
	us-gaap	Fee Income FeeIncome	4233120	usd
	us-gaap	Other Operating Income OtherOperatingIncome	140873	usd
	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	5070958	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3183515	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	829474	usd
	us-gaap	Professional Fees ProfessionalFees	1241089	usd
	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	408875	usd
	MDBH	Clearing And Other Charges ClearingAndOtherCharges	382994	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	883233	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6929180	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	67095	usd
	us-gaap	Operating Expenses OperatingExpenses	6996275	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1925317	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	548479	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1376838	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	384143	usd
	us-gaap	Profit Loss ProfitLoss	-1760981	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-341631	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1419350	usd
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	533680	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.44
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y9M29D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	51940	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.32
	MDBH	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P7Y
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	585620	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.44
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y9M29D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	457067	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.32
CY2023Q4	MDBH	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P7Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1042687	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.43
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y5M19D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	725878	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.00
	MDBH	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P7Y
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3376	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	12206	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	2.44
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1752983	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.57
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	288959	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.52
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y6M14D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	638144	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.62
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y3D
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	1115200	usd
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	829474	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	51297	usd
CY2024Q3	srt	Net Capital NetCapital	11515823	usd
CY2023Q3	srt	Net Capital NetCapital	5787743	usd
CY2024Q3	srt	Minimum Net Capital Required1 MinimumNetCapitalRequired1	7034937	usd
	us-gaap	Other Commitments Description OtherCommitmentsDescription	0.60
CY2024Q3	us-gaap	Ratio Of Indebtedness To Net Capital1 RatioOfIndebtednessToNetCapital1	0.02	pure
CY2024Q3	srt	Minimum Net Capital Required For Entity1 MinimumNetCapitalRequiredForEntity1	0	usd
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	426432	usd
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	391960	usd
	MDBH	Payment For Licensed Products PaymentForLicensedProducts	250000	usd
	MDBH	Cumulative Net Sales CumulativeNetSales	1000000	usd
CY2023Q2	us-gaap	Advance Rent AdvanceRent	14371	usd
CY2023Q2	MDBH	Base Rent BaseRent	16747	usd
CY2023Q2	MDBH	Annual Operating Cost Increase Percentage AnnualOperatingCostIncreasePercentage	0.025	pure
CY2023Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P12M
CY2023Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P60M
CY2023Q4	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	option to extend for 60 additional months
CY2023Q4	us-gaap	Advance Rent AdvanceRent	13277	usd
CY2023Q4	MDBH	Base Rent BaseRent	15391	usd
CY2023Q4	MDBH	Annual Operating Cost Increase Percentage AnnualOperatingCostIncreasePercentage	0.030	pure
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P91M
CY2022Q3	us-gaap	Advance Rent AdvanceRent	12556	usd
CY2022Q3	MDBH	Base Rent BaseRent	13937	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2062015	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2320119	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2181780	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2415889	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y10M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y3M29D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0766	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0740	pure
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	366948	usd
CY2023	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	206837	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1018002	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	132839	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	146836	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	258104	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	275589	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	390943	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	422425	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	124676	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	503684	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	516001	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	528586	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	541674	usd
CY2024Q3	MDBH	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	451600	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2666221	usd
CY2024Q3	MDBH	Less Effects Of Discounting LessEffectsOfDiscounting	-484441	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2181780	usd
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.27	pure

Files In Submission

Name	View Source	Status
0001493152-24-044825-index-headers.html	Edgar Link	pending
0001493152-24-044825-index.html	Edgar Link	pending
0001493152-24-044825.txt	Edgar Link	pending
0001493152-24-044825-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
mdbh-20240930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
mdbh-20240930_cal.xml	Edgar Link	unprocessable
mdbh-20240930_def.xml	Edgar Link	unprocessable
mdbh-20240930_lab.xml	Edgar Link	unprocessable
mdbh-20240930_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MDBH
MDB Capital Holdings LLC Stock $mdbh

2024 Q4 Form 10-Q Financial Statement

#000149315224044825 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDBH MDB Capital Holdings LLC Stock $mdbh

2024 Q4 Form 10-Q Financial Statement

#000149315224044825 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDBH
MDB Capital Holdings LLC Stock $mdbh